img

Global Organ Transplant Immunosuppressant Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Organ Transplant Immunosuppressant Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Immunosuppressants are a class of drugs that suppress the immune response through various mechanisms. In organ transplantation, immunosuppressants are used to prevent the body from either recognition or attacking the foreign organ via various immune responses. They should only be used under the supervision of appropriately trained and experienced staff.
Organ Transplant Immunosuppressant report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Organ Transplant Immunosuppressant market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Liver Transplant and Kidney Transplant are the major drivers for the industry.
In China, Organ Transplant Immunosuppressant key players include Roche, Astellas Pharma Inc., Huadong Pharmaceutical, Novartis, etc.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Organ Transplant Immunosuppressant market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Roche
Astellas Pharma Inc.
Huadong Pharmaceutical
Novartis
Catalent Pharma
Cinkate Corporation
Cilag
Genzyme
Changzhou Pharm
North China Pharmaceutical Group Corporation
SL PHARM
Livzon Pharmaceutical Group Inc.,
Segment by Type
Tacrolimus
Mycophenolate Mofetil
Cyclosporin
Others

Segment by Application


Liver Transplant
Kidney Transplant
Heart Transplant
Other Organ Transplant

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Organ Transplant Immunosuppressant market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Organ Transplant Immunosuppressant, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Organ Transplant Immunosuppressant industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Organ Transplant Immunosuppressant in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Organ Transplant Immunosuppressant introduction, etc. Organ Transplant Immunosuppressant Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Organ Transplant Immunosuppressant market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Organ Transplant Immunosuppressant Market Overview
1.1 Organ Transplant Immunosuppressant Product Overview
1.2 Organ Transplant Immunosuppressant Market Segment by Type
1.2.1 Tacrolimus
1.2.2 Mycophenolate Mofetil
1.2.3 Cyclosporin
1.2.4 Others
1.3 Global Organ Transplant Immunosuppressant Market Size by Type
1.3.1 Global Organ Transplant Immunosuppressant Market Size Overview by Type (2018-2034)
1.3.2 Global Organ Transplant Immunosuppressant Historic Market Size Review by Type (2018-2024)
1.3.3 Global Organ Transplant Immunosuppressant Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Organ Transplant Immunosuppressant Sales Breakdown by Type (2018-2024)
1.4.2 Europe Organ Transplant Immunosuppressant Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Organ Transplant Immunosuppressant Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Organ Transplant Immunosuppressant Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Organ Transplant Immunosuppressant Sales Breakdown by Type (2018-2024)
2 Global Organ Transplant Immunosuppressant Market Competition by Company
2.1 Global Top Players by Organ Transplant Immunosuppressant Sales (2018-2024)
2.2 Global Top Players by Organ Transplant Immunosuppressant Revenue (2018-2024)
2.3 Global Top Players by Organ Transplant Immunosuppressant Price (2018-2024)
2.4 Global Top Manufacturers Organ Transplant Immunosuppressant Manufacturing Base Distribution, Sales Area, Product Type
2.5 Organ Transplant Immunosuppressant Market Competitive Situation and Trends
2.5.1 Organ Transplant Immunosuppressant Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Organ Transplant Immunosuppressant Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Organ Transplant Immunosuppressant as of 2022)
2.7 Date of Key Manufacturers Enter into Organ Transplant Immunosuppressant Market
2.8 Key Manufacturers Organ Transplant Immunosuppressant Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Organ Transplant Immunosuppressant Status and Outlook by Region
3.1 Global Organ Transplant Immunosuppressant Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Organ Transplant Immunosuppressant Historic Market Size by Region
3.2.1 Global Organ Transplant Immunosuppressant Sales in Volume by Region (2018-2024)
3.2.2 Global Organ Transplant Immunosuppressant Sales in Value by Region (2018-2024)
3.2.3 Global Organ Transplant Immunosuppressant Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Organ Transplant Immunosuppressant Forecasted Market Size by Region
3.3.1 Global Organ Transplant Immunosuppressant Sales in Volume by Region (2024-2034)
3.3.2 Global Organ Transplant Immunosuppressant Sales in Value by Region (2024-2034)
3.3.3 Global Organ Transplant Immunosuppressant Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Organ Transplant Immunosuppressant by Application
4.1 Organ Transplant Immunosuppressant Market Segment by Application
4.1.1 Liver Transplant
4.1.2 Kidney Transplant
4.1.3 Heart Transplant
4.1.4 Other Organ Transplant
4.2 Global Organ Transplant Immunosuppressant Market Size by Application
4.2.1 Global Organ Transplant Immunosuppressant Market Size Overview by Application (2018-2034)
4.2.2 Global Organ Transplant Immunosuppressant Historic Market Size Review by Application (2018-2024)
4.2.3 Global Organ Transplant Immunosuppressant Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Organ Transplant Immunosuppressant Sales Breakdown by Application (2018-2024)
4.3.2 Europe Organ Transplant Immunosuppressant Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Organ Transplant Immunosuppressant Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Organ Transplant Immunosuppressant Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Organ Transplant Immunosuppressant Sales Breakdown by Application (2018-2024)
5 North America Organ Transplant Immunosuppressant by Country
5.1 North America Organ Transplant Immunosuppressant Historic Market Size by Country
5.1.1 North America Organ Transplant Immunosuppressant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Organ Transplant Immunosuppressant Sales in Volume by Country (2018-2024)
5.1.3 North America Organ Transplant Immunosuppressant Sales in Value by Country (2018-2024)
5.2 North America Organ Transplant Immunosuppressant Forecasted Market Size by Country
5.2.1 North America Organ Transplant Immunosuppressant Sales in Volume by Country (2024-2034)
5.2.2 North America Organ Transplant Immunosuppressant Sales in Value by Country (2024-2034)
6 Europe Organ Transplant Immunosuppressant by Country
6.1 Europe Organ Transplant Immunosuppressant Historic Market Size by Country
6.1.1 Europe Organ Transplant Immunosuppressant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Organ Transplant Immunosuppressant Sales in Volume by Country (2018-2024)
6.1.3 Europe Organ Transplant Immunosuppressant Sales in Value by Country (2018-2024)
6.2 Europe Organ Transplant Immunosuppressant Forecasted Market Size by Country
6.2.1 Europe Organ Transplant Immunosuppressant Sales in Volume by Country (2024-2034)
6.2.2 Europe Organ Transplant Immunosuppressant Sales in Value by Country (2024-2034)
7 Asia-Pacific Organ Transplant Immunosuppressant by Region
7.1 Asia-Pacific Organ Transplant Immunosuppressant Historic Market Size by Region
7.1.1 Asia-Pacific Organ Transplant Immunosuppressant Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Organ Transplant Immunosuppressant Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Organ Transplant Immunosuppressant Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Organ Transplant Immunosuppressant Forecasted Market Size by Region
7.2.1 Asia-Pacific Organ Transplant Immunosuppressant Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Organ Transplant Immunosuppressant Sales in Value by Region (2024-2034)
8 Latin America Organ Transplant Immunosuppressant by Country
8.1 Latin America Organ Transplant Immunosuppressant Historic Market Size by Country
8.1.1 Latin America Organ Transplant Immunosuppressant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Organ Transplant Immunosuppressant Sales in Volume by Country (2018-2024)
8.1.3 Latin America Organ Transplant Immunosuppressant Sales in Value by Country (2018-2024)
8.2 Latin America Organ Transplant Immunosuppressant Forecasted Market Size by Country
8.2.1 Latin America Organ Transplant Immunosuppressant Sales in Volume by Country (2024-2034)
8.2.2 Latin America Organ Transplant Immunosuppressant Sales in Value by Country (2024-2034)
9 Middle East and Africa Organ Transplant Immunosuppressant by Country
9.1 Middle East and Africa Organ Transplant Immunosuppressant Historic Market Size by Country
9.1.1 Middle East and Africa Organ Transplant Immunosuppressant Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Organ Transplant Immunosuppressant Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Organ Transplant Immunosuppressant Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Organ Transplant Immunosuppressant Forecasted Market Size by Country
9.2.1 Middle East and Africa Organ Transplant Immunosuppressant Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Organ Transplant Immunosuppressant Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Roche Organ Transplant Immunosuppressant Products Offered
10.1.5 Roche Recent Development
10.2 Astellas Pharma Inc.
10.2.1 Astellas Pharma Inc. Company Information
10.2.2 Astellas Pharma Inc. Introduction and Business Overview
10.2.3 Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Astellas Pharma Inc. Organ Transplant Immunosuppressant Products Offered
10.2.5 Astellas Pharma Inc. Recent Development
10.3 Huadong Pharmaceutical
10.3.1 Huadong Pharmaceutical Company Information
10.3.2 Huadong Pharmaceutical Introduction and Business Overview
10.3.3 Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Huadong Pharmaceutical Organ Transplant Immunosuppressant Products Offered
10.3.5 Huadong Pharmaceutical Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Novartis Organ Transplant Immunosuppressant Products Offered
10.4.5 Novartis Recent Development
10.5 Catalent Pharma
10.5.1 Catalent Pharma Company Information
10.5.2 Catalent Pharma Introduction and Business Overview
10.5.3 Catalent Pharma Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Catalent Pharma Organ Transplant Immunosuppressant Products Offered
10.5.5 Catalent Pharma Recent Development
10.6 Cinkate Corporation
10.6.1 Cinkate Corporation Company Information
10.6.2 Cinkate Corporation Introduction and Business Overview
10.6.3 Cinkate Corporation Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Cinkate Corporation Organ Transplant Immunosuppressant Products Offered
10.6.5 Cinkate Corporation Recent Development
10.7 Cilag
10.7.1 Cilag Company Information
10.7.2 Cilag Introduction and Business Overview
10.7.3 Cilag Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Cilag Organ Transplant Immunosuppressant Products Offered
10.7.5 Cilag Recent Development
10.8 Genzyme
10.8.1 Genzyme Company Information
10.8.2 Genzyme Introduction and Business Overview
10.8.3 Genzyme Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Genzyme Organ Transplant Immunosuppressant Products Offered
10.8.5 Genzyme Recent Development
10.9 Changzhou Pharm
10.9.1 Changzhou Pharm Company Information
10.9.2 Changzhou Pharm Introduction and Business Overview
10.9.3 Changzhou Pharm Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Changzhou Pharm Organ Transplant Immunosuppressant Products Offered
10.9.5 Changzhou Pharm Recent Development
10.10 North China Pharmaceutical Group Corporation
10.10.1 North China Pharmaceutical Group Corporation Company Information
10.10.2 North China Pharmaceutical Group Corporation Introduction and Business Overview
10.10.3 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2018-2024)
10.10.4 North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Products Offered
10.10.5 North China Pharmaceutical Group Corporation Recent Development
10.11 SL PHARM
10.11.1 SL PHARM Company Information
10.11.2 SL PHARM Introduction and Business Overview
10.11.3 SL PHARM Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2018-2024)
10.11.4 SL PHARM Organ Transplant Immunosuppressant Products Offered
10.11.5 SL PHARM Recent Development
10.12 Livzon Pharmaceutical Group Inc.,
10.12.1 Livzon Pharmaceutical Group Inc., Company Information
10.12.2 Livzon Pharmaceutical Group Inc., Introduction and Business Overview
10.12.3 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Products Offered
10.12.5 Livzon Pharmaceutical Group Inc., Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Organ Transplant Immunosuppressant Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Organ Transplant Immunosuppressant Industrial Chain Analysis
11.4 Organ Transplant Immunosuppressant Market Dynamics
11.4.1 Organ Transplant Immunosuppressant Industry Trends
11.4.2 Organ Transplant Immunosuppressant Market Drivers
11.4.3 Organ Transplant Immunosuppressant Market Challenges
11.4.4 Organ Transplant Immunosuppressant Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Organ Transplant Immunosuppressant Distributors
12.3 Organ Transplant Immunosuppressant Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Tacrolimus
Table 2. Major Company of Mycophenolate Mofetil
Table 3. Major Company of Cyclosporin
Table 4. Major Company of Others
Table 5. Global Organ Transplant Immunosuppressant Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Organ Transplant Immunosuppressant Sales by Type (2018-2024) & (K Units)
Table 7. Global Organ Transplant Immunosuppressant Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Organ Transplant Immunosuppressant Sales by Type (2018-2024) & (US& Million)
Table 9. Global Organ Transplant Immunosuppressant Market Share in Value by Type (2018-2024)
Table 10. Global Organ Transplant Immunosuppressant Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Organ Transplant Immunosuppressant Sales by Type (2024-2034) & (K Units)
Table 12. Global Organ Transplant Immunosuppressant Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Organ Transplant Immunosuppressant Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Organ Transplant Immunosuppressant Sales Market Share in Value by Type (2024-2034)
Table 15. Global Organ Transplant Immunosuppressant Price by Type (2024-2034) & (US$/Unit)
Table 16. North America Organ Transplant Immunosuppressant Sales by Type (2018-2024) & (K Units)
Table 17. North America Organ Transplant Immunosuppressant Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Organ Transplant Immunosuppressant Sales (K Units) by Type (2018-2024)
Table 19. Europe Organ Transplant Immunosuppressant Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Organ Transplant Immunosuppressant Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Organ Transplant Immunosuppressant Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Organ Transplant Immunosuppressant Sales (K Units) by Type (2018-2024)
Table 23. Latin America Organ Transplant Immunosuppressant Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Organ Transplant Immunosuppressant Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Organ Transplant Immunosuppressant Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Organ Transplant Immunosuppressant Sales by Company (2018-2024) & (K Units)
Table 27. Global Organ Transplant Immunosuppressant Sales Share by Company (2018-2024)
Table 28. Global Organ Transplant Immunosuppressant Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Organ Transplant Immunosuppressant Revenue Share by Company (2018-2024)
Table 30. Global Market Organ Transplant Immunosuppressant Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Organ Transplant Immunosuppressant Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Organ Transplant Immunosuppressant Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Organ Transplant Immunosuppressant as of 2022)
Table 34. Date of Key Manufacturers Enter into Organ Transplant Immunosuppressant Market
Table 35. Key Manufacturers Organ Transplant Immunosuppressant Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Organ Transplant Immunosuppressant Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Organ Transplant Immunosuppressant Sales by Region (2018-2024) & (K Units)
Table 39. Global Organ Transplant Immunosuppressant Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Organ Transplant Immunosuppressant Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Organ Transplant Immunosuppressant Sales Market Share in Value by Region (2018-2024)
Table 42. Global Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Organ Transplant Immunosuppressant Sales by Region (2024-2034) & (K Units)
Table 44. Global Organ Transplant Immunosuppressant Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Organ Transplant Immunosuppressant Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Organ Transplant Immunosuppressant Sales Market Share in Value by Region (2024-2034)
Table 47. Global Organ Transplant Immunosuppressant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 48. Global Organ Transplant Immunosuppressant Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Organ Transplant Immunosuppressant Sales by Application (2018-2024) & (K Units)
Table 50. Global Organ Transplant Immunosuppressant Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Organ Transplant Immunosuppressant Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Organ Transplant Immunosuppressant Sales Market Share in Value by Application (2018-2024)
Table 53. Global Organ Transplant Immunosuppressant Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Organ Transplant Immunosuppressant Sales by Application (2024-2034) & (K Units)
Table 55. Global Organ Transplant Immunosuppressant Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Organ Transplant Immunosuppressant Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Organ Transplant Immunosuppressant Sales Market Share in Value by Application (2024-2034)
Table 58. Global Organ Transplant Immunosuppressant Price by Application (2024-2034) & (US$/Unit)
Table 59. North America Organ Transplant Immunosuppressant Sales by Application (2018-2024) (K Units)
Table 60. North America Organ Transplant Immunosuppressant Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Organ Transplant Immunosuppressant Sales by Application (2018-2024) (K Units)
Table 62. Europe Organ Transplant Immunosuppressant Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Organ Transplant Immunosuppressant Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Organ Transplant Immunosuppressant Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Organ Transplant Immunosuppressant Sales by Application (2018-2024) (K Units)
Table 66. Latin America Organ Transplant Immunosuppressant Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Organ Transplant Immunosuppressant Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Organ Transplant Immunosuppressant Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Organ Transplant Immunosuppressant Sales by Country (2018-2024) & (K Units)
Table 70. North America Organ Transplant Immunosuppressant Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Organ Transplant Immunosuppressant Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Organ Transplant Immunosuppressant Sales Market Share in Value by Country (2018-2024)
Table 73. North America Organ Transplant Immunosuppressant Sales by Country (2024-2034) & (K Units)
Table 74. North America Organ Transplant Immunosuppressant Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Organ Transplant Immunosuppressant Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Organ Transplant Immunosuppressant Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Organ Transplant Immunosuppressant Sales by Country (2018-2024) & (K Units)
Table 78. Europe Organ Transplant Immunosuppressant Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Organ Transplant Immunosuppressant Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Organ Transplant Immunosuppressant Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Organ Transplant Immunosuppressant Sales by Country (2024-2034) & (K Units)
Table 82. Europe Organ Transplant Immunosuppressant Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Organ Transplant Immunosuppressant Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Organ Transplant Immunosuppressant Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Organ Transplant Immunosuppressant Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Organ Transplant Immunosuppressant Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Organ Transplant Immunosuppressant Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Organ Transplant Immunosuppressant Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Organ Transplant Immunosuppressant Sales by Region (2024-2034) & (K Units)
Table 90. Asia-Pacific Organ Transplant Immunosuppressant Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Organ Transplant Immunosuppressant Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Organ Transplant Immunosuppressant Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Organ Transplant Immunosuppressant Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Organ Transplant Immunosuppressant Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Organ Transplant Immunosuppressant Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Organ Transplant Immunosuppressant Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Organ Transplant Immunosuppressant Sales by Country (2024-2034) & (K Units)
Table 98. Latin America Organ Transplant Immunosuppressant Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Organ Transplant Immunosuppressant Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Organ Transplant Immunosuppressant Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Organ Transplant Immunosuppressant Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Organ Transplant Immunosuppressant Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Organ Transplant Immunosuppressant Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Organ Transplant Immunosuppressant Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Organ Transplant Immunosuppressant Sales by Country (2024-2034) & (K Units)
Table 106. Middle East and Africa Organ Transplant Immunosuppressant Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Organ Transplant Immunosuppressant Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Organ Transplant Immunosuppressant Sales Market Share in Value by Country (2024-2034)
Table 109. Roche Company Information
Table 110. Roche Introduction and Business Overview
Table 111. Roche Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Roche Organ Transplant Immunosuppressant Product
Table 113. Roche Recent Development
Table 114. Astellas Pharma Inc. Company Information
Table 115. Astellas Pharma Inc. Introduction and Business Overview
Table 116. Astellas Pharma Inc. Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Astellas Pharma Inc. Organ Transplant Immunosuppressant Product
Table 118. Astellas Pharma Inc. Recent Development
Table 119. Huadong Pharmaceutical Company Information
Table 120. Huadong Pharmaceutical Introduction and Business Overview
Table 121. Huadong Pharmaceutical Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Huadong Pharmaceutical Organ Transplant Immunosuppressant Product
Table 123. Huadong Pharmaceutical Recent Development
Table 124. Novartis Company Information
Table 125. Novartis Introduction and Business Overview
Table 126. Novartis Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Novartis Organ Transplant Immunosuppressant Product
Table 128. Novartis Recent Development
Table 129. Catalent Pharma Company Information
Table 130. Catalent Pharma Introduction and Business Overview
Table 131. Catalent Pharma Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Catalent Pharma Organ Transplant Immunosuppressant Product
Table 133. Catalent Pharma Recent Development
Table 134. Cinkate Corporation Company Information
Table 135. Cinkate Corporation Introduction and Business Overview
Table 136. Cinkate Corporation Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Cinkate Corporation Organ Transplant Immunosuppressant Product
Table 138. Cinkate Corporation Recent Development
Table 139. Cilag Company Information
Table 140. Cilag Introduction and Business Overview
Table 141. Cilag Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Cilag Organ Transplant Immunosuppressant Product
Table 143. Cilag Recent Development
Table 144. Genzyme Company Information
Table 145. Genzyme Introduction and Business Overview
Table 146. Genzyme Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. Genzyme Organ Transplant Immunosuppressant Product
Table 148. Genzyme Recent Development
Table 149. Changzhou Pharm Company Information
Table 150. Changzhou Pharm Introduction and Business Overview
Table 151. Changzhou Pharm Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Changzhou Pharm Organ Transplant Immunosuppressant Product
Table 153. Changzhou Pharm Recent Development
Table 154. North China Pharmaceutical Group Corporation Company Information
Table 155. North China Pharmaceutical Group Corporation Introduction and Business Overview
Table 156. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. North China Pharmaceutical Group Corporation Organ Transplant Immunosuppressant Product
Table 158. North China Pharmaceutical Group Corporation Recent Development
Table 159. SL PHARM Company Information
Table 160. SL PHARM Introduction and Business Overview
Table 161. SL PHARM Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. SL PHARM Organ Transplant Immunosuppressant Product
Table 163. SL PHARM Recent Development
Table 164. Livzon Pharmaceutical Group Inc., Company Information
Table 165. Livzon Pharmaceutical Group Inc., Introduction and Business Overview
Table 166. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Livzon Pharmaceutical Group Inc., Organ Transplant Immunosuppressant Product
Table 168. Livzon Pharmaceutical Group Inc., Recent Development
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Organ Transplant Immunosuppressant Market Trends
Table 172. Organ Transplant Immunosuppressant Market Drivers
Table 173. Organ Transplant Immunosuppressant Market Challenges
Table 174. Organ Transplant Immunosuppressant Market Restraints
Table 175. Organ Transplant Immunosuppressant Distributors List
Table 176. Organ Transplant Immunosuppressant Downstream Customers
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Organ Transplant Immunosuppressant Product Picture
Figure 2. Global Organ Transplant Immunosuppressant Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Organ Transplant Immunosuppressant Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Organ Transplant Immunosuppressant Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Tacrolimus
Figure 6. Global Tacrolimus Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Mycophenolate Mofetil
Figure 8. Global Mycophenolate Mofetil Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Cyclosporin
Figure 10. Global Cyclosporin Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Global Organ Transplant Immunosuppressant Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Organ Transplant Immunosuppressant Sales Market Share by Type in 2022 & 2034
Figure 15. North America Organ Transplant Immunosuppressant Sales Market Share in Volume by Type in 2022
Figure 16. North America Organ Transplant Immunosuppressant Sales Market Share in Value by Type in 2022
Figure 17. Europe Organ Transplant Immunosuppressant Sales Market Share in Volume by Type in 2022
Figure 18. Europe Organ Transplant Immunosuppressant Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Organ Transplant Immunosuppressant Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Organ Transplant Immunosuppressant Sales Market Share in Value by Type in 2022
Figure 21. Latin America Organ Transplant Immunosuppressant Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Organ Transplant Immunosuppressant Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Organ Transplant Immunosuppressant Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Organ Transplant Immunosuppressant Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Organ Transplant Immunosuppressant Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Organ Transplant Immunosuppressant Revenue in 2022
Figure 27. Organ Transplant Immunosuppressant Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Liver Transplant
Figure 29. Global Liver Transplant Sales YoY Growth (2018-2034) & (K Units)
Figure 30. Product Picture of Kidney Transplant
Figure 31. Global Kidney Transplant Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Heart Transplant
Figure 33. Global Heart Transplant Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Other Organ Transplant
Figure 35. Global Other Organ Transplant Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Global Organ Transplant Immunosuppressant Sales by Application (2018-2034) & (US$ Million)
Figure 37. Global Organ Transplant Immunosuppressant Sales Market Share by Application in 2022 & 2034
Figure 38. North America Organ Transplant Immunosuppressant Sales Market Share in Volume by Application in 2022
Figure 39. North America Organ Transplant Immunosuppressant Sales Market Share in Value by Application in 2022
Figure 40. Europe Organ Transplant Immunosuppressant Sales Market Share in Volume by Application in 2022
Figure 41. Europe Organ Transplant Immunosuppressant Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Organ Transplant Immunosuppressant Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Organ Transplant Immunosuppressant Sales Market Share in Value by Application in 2022
Figure 44. Latin America Organ Transplant Immunosuppressant Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Organ Transplant Immunosuppressant Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Organ Transplant Immunosuppressant Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Organ Transplant Immunosuppressant Manufacturing Cost Structure
Figure 49. Organ Transplant Immunosuppressant Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries